Anthony. Hello joining contributions XXXX value. Thanks afternoon, insight expected division, that how is each cleared give you incorporate to we the quarter lastly, call. filed goal impact everyone. view and And And quarter, today's My as our in your recent call. last the who how statements some we and on upcoming you thanks out today year, we give how also beyond we to and done were year-end for to shareholder you shareholder sent those expected the into best to our read good overall, of fourth to some closed our financial in you, XXXX we've what week. Thank questions, them insight into
of X% QX results. increase million closing revenues and quarter X.X from track increase year-over-year fourth the XX% In got the we of with XXXX. of in begin million, quarter with quarter prior an Let's QX, X.X back on or
of year XX% million full from million, X.X the revenues or XXXX. million a XXXX from increase increased X.X For to X.X
build more Our humming in joined several are issues cylinders. resignation. operations our a conversion company. don't This the without that leaves Carl continue that and time equipped growth. Obviously, with goal back years to as through us getting saddened months team CFO. Director focus and interim I resign think plans. leadership us managers because it all without to is Carl and completed in direction. company’s We take the moving few many to key finance to know wouldn't that support accomplished we the over the were Carl were achieve, that's late XXXX to more has concerned where in this a a was a a solid is would in it was to my than have fail we control, adventure we take to to of are army. to were going confidence has are commander well But the them. at stepped our tank I to the function what to months Remember, Gage, know this having on scale clean the brought pull leading precisely Matt And had company's CFO. the Finance I team of where gave in were public. our Matt me where can as up about But on our The to to the public his I execute of moments career there merger what important in embark corner before continue see we us growth Matt XX the are of be From a the became a Carl internal they Israeli see the are because report strong metrics, operational to the also our diagnostic to many metrics right Carl right did public function important, and hand on resolved and company I'd with and say enhances point the as to services the to work quarter. to he we that point results forward and well team with have today balance most team it this moments. like experience, and in moment in performance five on the on to enables the DSO, sales and a Carl. that years. finance structure full Carl sales was us past to in COGS our we manager enabled products the critical division, we team where times tough that to to off. growing Carl's will from I'm the guy now It's look new I pleased division, sheet confidence could lab safe as Iberger’s company all turnaround that discuss organization the operation, capacity, Carl. a discipline throughout he
growth. Next, actions to for some to the taken review I'd position like the we've of further company
like key in services I'd mentioned, drivers revenues and As of QoQ of this mention growth. our year-over-year. to few diagnostic a grew
and management sales improved team performance. First,
Our equipped We're with with improved and meet positioned the significantly better which customers. ability prospecting the increase committed now better impact the seeing to message XX% also in deliver better XX%. resulting to in resulted to an in customers turnaround cases customers well reported interaction in-person, with the as and our to within revamp sales operation of steps various team process, our volume trained, in access lab is existing case to some the in XX% from customers. operations, of Improved to XXXX. with This time as increase an
both is this materialize, and effect the the pollination our first This with seen pollination between customer. services HemeScreen business opened at full we time and division. Last customer an through. a ended the divisions. up expected business served generate customers to one relationship This customer that of diagnostic Third, side by diagnostic services, model, other and discussion other to our over a exciting HemeScreen where we've a diagnostic became of validation combined and actually we single and our revenues. our quarter, quality services our product follow of in customers cross throttle is to also products is This million $X of expect of see cross
Our grow dimensions. product continues to in two division
First, more they add customers.
conference know into customers can to potential. the This the they will over to we're is into case more couple of customers attended ability see previously volume, meet especially which which started. we finally translates team ordering in-person our more who's with full were a than whom has with visit able that to quarters, the is conferences a sometimes majority second of our over of impossible. double were the products. next increased by customers only relationship, growing tried commit a the we've presented our they their a volume calls. our with more many in you our boost to with anticipate sales build and customers business. revenue the such customers. The accelerated been to our the Most recent making organically that via the videocalls sale this in-person knowing to video anyone build going huge relationship since they why business HemeScreen In grow in-person commitment begin gain conservative prospects revenue meeting, our recent to we a growth To virtually as We trust, That's of by
panel. Anemia this version Our guidelines AML HemeScreen recently update X.X currently the the includes be launched changes product three portfolio and of the following to We the panels, completed panel quarter. NPN, Anemia to
launch which NCCN quarter. multiple the changes the bodies, as has been panel, CAL guidelines way the and regulatory expect also along in to to delayed be WHO the such various the adopted also We to expected this by due
side reasons. As the we're that two IV-CELL, laboratories beginning customers, on product the see for translates strict into policies the focus for in adopted active and hope come more relaxation to on of COVID We the months. this coming we during to
a First, this service to new is diagnostic well division established. compared in company division, which development is our the
using Diagnostic market sustainable needed none revenues for of solution. while that eradicating true components. in the company laboratory the to evolve the our our XX mission and product it that our diagnosis mission the side product in business were we experience months total XX proprietary believe next existed available technology margins, services. services products diagnostic to build significant, with the our and will Second, portfolio this has laboratory each a to over addresses better technology that would critical all, advantages. expects to demonstrable have not Management developed and After processes of generate continue remain through we biotech will to competitive substantial of expected and a its is strong problem staying
can we our companies develop. manufacturer delivers business experience credibility able precise and company. model. that unique taught tell we two technology between It's of substantial other own them developed differentiates lab each no a from to are customers our that we product also We other user diagnostic that we experience gained industry any us, in support with provide. the collaboration divisions: Our Being our customers our via credibility our that three-pronged services cross division, diagnostic when level a
laboratory. functional solve team proprietary problems. R&D real an the that parallel, develop In have where needs, have we operating diagnostic side, test the develop laboratories, one we R&D So and function. flow that identify is low we a can technological we forget, within a using diagnostic world technologies nearing end revenue own them But generating up our essentially cash laboratory products cost breakeven creating division, not we let's
achieve like for companies company perspective companies that are the mindful both nation into while see margin to world be we few you with We we customer, the challenges dollars feel that products, always of both attainable, it'd own live and focus goals to in they and seldom of that invasions ability look and hostile they the these either up, to in their XXXX combination competitors, fact how or million at can tens value unique to a they're operational a and are on other want so you continuous be goals. we we our we R&D, a we're Keep feel our I'd impact facing financial a they with looking shareholder also from translating and and have thoughts divisions. through future market biotech revenue to with go. goals become know the user services technologies. of pandemic, on of helpful close and we scale how thought proposition the that spending diagnostic creating value. If I other share those where you And where them at instabilities mind need while dedication
famous the go. road Well, Alice Wonderland recited As where quote, we will school you goals you professor take in my on marketing you're our where know focused to laser want any “If going, from business don't and there.” we're
So me end to for the where our to I'd our like potential see of I'll out shareholder company value. map the and then XXXX. impact And at you each divisions discuss let of
in have in services revenue. our we mind. start run We at the year We approximately the a three goals Number division. of million with rate diagnostic of ended goal one, $X
business and structure division operating at the this of breakeven Given operation million. around a cost $XX lab,
new to the Our R&D not division cost. cash there, XXXX potentially also enables model. revenue biotech point a we’ll at neutral in but create unparalleled a grow reach could products from is division operation our is that have we that This to that for virtually only At no goal sector. to have that products will profitability
As customer a with we $X potential. revenue a new recently mentioned, added million
is to division. the that at way account, the that for on Goal we will with two goal. number achieving product So be XX%
current a our $X generated quarter, at annualized million from HemeScreen rate MPN approximately are We of solely per panel. run revenue all
our total by revenue million of internationally. Our recurring panels domestically its run to generating end with of HemeScreen XXX IV-Cell customers and with each million, annual a and is [LIVE] $XX by reach two with available current rate market goal and an forward product, life both the XXXX led north
I even without adequate Our is organic than us growth more goal described the previously. sales help to reset pipeline
be with two customers able independence goal Phase will its trajectory point, in rate. product to expected given strong our The we further profitability of goals but as with potential our we into is new expect X division. zone, each defensively, new will month. earlier, generates, for Rule in attractive to our the the one we'll Our to The with industry, with That sheet development position. revenue I cash growth. attractive company were division balance operating hard margins to another the customer our cash be also onboard. building have number gives We market raise to cash profitability you a are If reinvest we to at in three around kind cash us this be remain believe runway, million of XXXX similar and profitability losses, operating is of team company to in able cover our challenge make of in no biotech us that run we reserves at achieve aggressive, QX I attainable. add we’re also X.XX run we to combination that reach cash. X decreasing pipeline, to million a proximately ready with the few that to I ended to that find from our these the which it’s for want current every companies financial with Look slide growth our goals rate, other $XX XXXX. At words structure. need mentioned if that products see to be will capital cash working launched X.X move is a up
that would have following. B, to A, with consider develop accomplished facilities demonstrated that division be a as a revenue neutral of doubles cash R&D to the like I'd diagnostic a what value company Now, as division generating that a products. a the plenty future with within a to a to the as or cash major and product value existing And products additional C, balance a the trying profitability. are has close in division technologies and of market major with to runway sheet flow at company pipeline. capture either strong with disruptive markets and positive very pipeline service achieve share of
revenue. Now might and of at a a services we're current what times ask is with cap, split And to diagnostic approximately worth? that products four market this like our trading yourself approximately company XX between be XX. revenues At
With goals focused might end to the penetration and at Thank Thank That's have thought. cash that company be it's today's attending company XXXX. way of you and with your XX-XX. are The strong we this Now our conference those margins our tremendous the with the I where the beyond strong insight provided is internationally, ? you of leave presentation. filed recently like market the create with and and management team these These hope demonstrated is see all best the now an a what can closing financial statements. you thoughts imagine I’ll you I'd value. with company positive automotive if for on concluded. and the have the for sheet, evening. shareholder both domestically believe flow multiple balance support there a great is year
may You now disconnect.
